Moujaro, built by Ellie Lily and the company’s packaging, has been seen in a pharmacy photo taken in a pharmacy in Cracko, Poland on 9 April 2024.
Nurphoto | Nurphoto | Getty images
Ellie lily Said on Thursday that it is Raise list value Its blockbuster diabetes drug Maunjaro in UK starting in September, as President Donald Trump Pressure to drug manufacturers Low American medicine prices And they increase abroad.
In a statement, Elli Lily stated that it reached an agreement with the UK government to increase the list of weekly injections during the publicly funded health care system, national healthcare, or patients covered under NHS.
Elli Lily told CNBC that the price increase would not affect the availability of drug under NHS, and it wants to work with the government to promote access. The company said it does not determine the prices that private health care providers have determined, but are working with them to ensure access to Munjaro.
In a statement on Thursday, the NHS stated that the list of mounjaro will not affect the NHS of TIRJPetide in England for the eligible people living with obesity, as the treatment of type 2 diabetes, or as the treatment of type 2 diabetes. ” Tirzepatide Mounjaro has an active ingredient and weight loss, its equivalent for zepbound.
The current list of mounjaro in the UK is according to Elli Lily, depending on the size of dose from £ 92 (approximately $ 124.89) to £ 122 per month. The new list of drugs will start between £ 133 and £ 330 to start from 1 September.
The company said that it is working with some governments and expects to make pricing adjustments in those countries till that date. In the US, the list price for a month supply is $ 1,079.77 before the price, insurance and other discounts.
Elli Lily stated that it supports America the target of the Trump administration to “keep the world’s major destination for bioframacutical research and manufacturing, and the purpose of sharing the costs of success medical research in developed countries.”
The company said in the statement, “This imbalance can be difficult, but this means that the prices of drugs paid by governments and health systems need to grow in other developed markets like Europe.”
Announced after Trump in July Separate letters to 17 drug manufacturersIncluding Eli Lily, calling them to call them to reduce the drug prices by 29 September. Steps built on the Executive Order of the President in May – a controversial plan – to revive the “most preferred nation” policy – aims to reduce the cost of the drug by tying some drug prices in the US, which are up to very few people abroad.
According to a public policy think tank Rand Corp, the prices of US prescription drugs are two to three times higher than other developed nations-and 10 times higher than some countries. Trump has said that he wants to narrow that difference to prevent Americans from “bursting”.
Elli Lily’s announcement on Thursday comes in the form of industry braces for Trump’s planned tariff on imported pharmaceuticals in the US, the company said that it opposes those tariffs, arguing that they will “increase the cost, limit the reach, limit the reach, and reduce the US leadership, especially the companies are already investing huge in domestic construction for companies.”
In recent months, Eli Lily was one of the several drug manufacturers, who announced new plans to invest in US manufacturing sites.
